InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Related Stories

Aerospike’s New Expression Indexes Simplify Developer Code and Reduce Memory Overhead for Application and AI Queries

Inworld Runtime: The first AI runtime for consumer applications

AlayaCare selected to modernize 33 community support agencies, powering the next phase of digital transformation in community care

Pando Named to 2025 Inc. 5000 List of America’s Fastest Growing Private Companies

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical’s Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth

You may have missed

Aerospike’s New Expression Indexes Simplify Developer Code and Reduce Memory Overhead for Application and AI Queries

Inworld Runtime: The first AI runtime for consumer applications

AlayaCare selected to modernize 33 community support agencies, powering the next phase of digital transformation in community care

Pando Named to 2025 Inc. 5000 List of America’s Fastest Growing Private Companies

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical’s Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

error: Content is protected !!